I didn't say it was mentioned in a PR, but it was multiple times. Most relevant was the recent letter to shareholders from Les Goldman. Also listen to Linda's talk from the "A long awaited reality" conference, from 22:00 on. If, after reading and listening to that your arms are still crossed tight at the idea of ongoing Ph I/II data being presented at ASCO, then I would say you may be a touch stilted ;).